Close

Rating History for Celldex Therapeutics (CLDX) by Cantor Fitzgerald

More Stocks Rated by Cantor Fitzgerald | Latest Ratings for CLDX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/5/2023 Kristen Kluska Maintain Overweight
(N/A)		 54.00
(55.00)		  
 		   Details